ADAMTS13--marker of contractile phenotype of arterial smooth muscle cells lost in benign nephrosclerosis.
Abstract
BACKGROUND
Hypertensive nephrosclerosis alone and in combination with other renal diseases is a leading cause of terminal renal insufficiency.
Histologic lesions manifest as benign nephrosclerosis (bN) with arteriolar hyalinosis and later fibrosis. Procoagulant micromilieus
have been implicated in fibrosis. Hyalinosis is considered to consist of plasma insudation possibly containing procoagulant
factors like von Willebrand factor (VWF). Therefore, it is hypothesized that VWF cleaving protease ADAMTS13 (a disintegrin-like
and metalloprotease with thrombospondin type-1 motif, 13) is normally expressed by arteriolar vascular smooth muscle cells
(VSMCs) and diminished in bN and that this reduction contributes to fibrosis in bN.
METHODS
ADAMTS13 expression was examined by immunohistochemistry and quantitative real-time polymerase chain reaction in VSMCs of
various human organs. Fifty-four specimens with and seven without bN were immunostained for ADAMTS13, VWF, CD61 and VSMC differentiation
markers in arteriolar walls.
RESULTS
Expression of ADAMTS13 is confirmed in VSMCs. In bN, ADAMTS13 immunostaining of arterial VSMCs correlated inversely with fibrotic
but not hyalinotic lesions. Smooth muscle myosin heavy chain showed an inverse correlation with hyalinotic, as opposed to
fibrotic lesions of bN. Smoothelin showed an inverse correlation with both hyalinotic and fibrotic lesions of bN. VWF was
absent in normal controls and hyalinotic lesions, but present exclusively in fibrotic lesions in 7/54 (13%) bN cases. CD61
was absent in all arteriolar walls.
CONCLUSIONS
The present results establish ADAMTS13 as a novel marker of contractile VSMCs that is retained in early hyalinotic bN but
partially lost later in fibrotic bN. Loss of ADAMTS13 and accumulation of VWF in fibrotic but not hyalinotic arteriolar walls
could further propagate fibrosis in bN.
Links
Authors
Bockmeyer CL, Forstmeier V, Modde F, Lovric S, Claus RA, Schiffer M, Agustian PA, Grothusen C, Grote K, Birschmann I, Theophile K, Kreipe HH, Bröcker V, Becker JU
Institution
Institute of Pathology, Hannover Medical School, Hannover, Lower Saxony, Germany.
Source
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 26:6 2011 Jun pg 1871-81MeSH
ADAM ProteinsArteries
Biological Markers
Case-Control Studies
Humans
Immunoenzyme Techniques
Integrin beta3
Muscle Contraction
Myocytes, Smooth Muscle
Nephrosclerosis
Prognosis
RNA, Messenger
Reverse Transcriptase Polymerase Chain Reaction
von Willebrand Factor
Pub Type(s)
Comparative StudyJournal Article
Language
eng
PubMed ID
20923926
Log In

